Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-Carboxamides

Despite more than 25 years of research, the molecular targets of quinoline-3-carboxamides have been elusive although these compounds are currently in Phase II and III development for treatment of autoimmune/inflammatory diseases in humans. Using photoaffinity cross-linking of a radioactively labelle...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Björk, Per, Björk, Anders, Vogl, Thomas, Stenström, Martin, Liberg, David, Olsson, Anders, Roth, Johannes, Ivars, Fredrik, Leanderson, Tomas
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2009
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2671563/
https://ncbi.nlm.nih.gov/pubmed/19402754
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pbio.1000097
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares